Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00631631 · ClinicalTrials.gov registry record
Mifamurtide (L-MTP-PE) for High-Risk Osteosarcoma
A clinical trial, sponsored by Millennium Pharmaceuticals.
- Completed
- Registry status
- 205
- Enrollment target
NCT00631631 is a clinical trial that has completed, run by Millennium Pharmaceuticals. The registered enrollment target is 205 participants.
The verdict
NCT00631631 has completed, sponsored by Millennium Pharmaceuticals.
- COMPLETED
- Registry status
- 205 participants
- Enrollment target
Study Summary
The purpose of this study was to collect information regarding the safety and tolerability of mifamurtide (liposomal muramyl tripeptide phosphatidyl ethanolamine; L-MTP-PE).
Interventions
- DRUG Mifamurtide (L-MTP-PE)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 205 participants |
| Start Date | 2008-01 |
| Est. Completion | 2012-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00631631
The ClinicalTrials.gov registry entry for NCT00631631 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 205 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Millennium Pharmaceuticals, which has 135 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mifamurtide (L-MTP-PE) is the first listed.
NCT00631631 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00631631 about?
NCT00631631 is a clinical study titled "Mifamurtide (L-MTP-PE) for High-Risk Osteosarcoma". The purpose of this study was to collect information regarding the safety and tolerability of mifamurtide (liposomal muramyl tripeptide phosphatidyl ethanolamine; L-MTP-PE).
What is the current status of trial NCT00631631?
This trial is currently completed. The enrollment target is 205 participants. The study started on 2008-01. Estimated completion is 2012-10.
What interventions are being tested in trial NCT00631631?
The interventions under investigation include: Mifamurtide (L-MTP-PE) (DRUG).
Who is sponsoring clinical trial NCT00631631?
This trial is sponsored by Millennium Pharmaceuticals, which has 135 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.